There were 1,828 press releases posted in the last 24 hours and 359,044 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
ヌマブ・セラピューティクス (Numab Therapeutics) および小野薬品工業株式会社が、がん治療用の多重特異性抗体NM49開発に関するオプションおよび提携契約を発表

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image